Hyoscyamus niger

cardiac arrhythmia, tachycardia-prone conditions, coronary artery disease, heart failure

Anticholinergic-induced tachycardia is reported in approximately 75% of H. niger poisoning cases (Alizadeh 2014). Individuals with pre-existing cardiac conditions face elevated risk of clinically significant arrhythmia. No H. niger-specific cardiac outcome studies exist, but the mechanism is well-characterized from tropane alkaloid pharmacology.

schizophrenia, schizoaffective disorder, psychotic spectrum disorders

Anticholinergic delirium involves hallucinations, delusions, and severely impaired reality testing — features that overlap with and may exacerbate psychotic spectrum disorders. No H. niger-specific data on psychiatric precipitation exist; this contraindication is based on clinical reasoning from the pharmacological profile.

hepatic impairment, liver disease, cirrhosis

Scopolamine metabolism involves CYP3A4 (Renner 2005). Individuals with hepatic impairment may have reduced CYP3A4 activity, leading to decreased alkaloid clearance and prolonged duration of toxic effects. No H. niger-specific hepatic impairment data exist; this contraindication is inferred from purified scopolamine pharmacokinetics.

urinary retention, benign prostatic hypertrophy

Urinary retention is a documented feature of anticholinergic syndrome. Individuals with pre-existing urinary retention or prostatic hypertrophy face elevated risk of acute urinary retention requiring catheterization.

pregnancy

Scopolamine is documented to cross the placental barrier (Renner 2005). Teratogenicity data are limited. No clinical trials of H. niger plant preparations in pregnant individuals exist. Any exposure during pregnancy should be treated as a medical emergency requiring clinical supervision.

pediatric age

Children are substantially more sensitive to anticholinergic toxicity than adults. The Alizadeh (2014) review reports that approximately 4 flowers can induce clinical anticholinergic manifestations in a pre-school child, though the primary citation for this figure has not been independently traced. Pediatric anticholinergic poisoning carries elevated risk of seizures, hyperthermia, and respiratory compromise.

elderly, advanced age

Elderly individuals demonstrate heightened anticholinergic sensitivity with significantly elevated risk of delirium. Long-term anticholinergic exposure is epidemiologically associated with increased dementia risk (Marzoughi et al. 2021). The combination of age-related pharmacokinetic changes (reduced hepatic clearance) and pharmacodynamic sensitivity (increased CNS vulnerability) creates substantially elevated risk.

tricyclic antidepressant use, first-generation antihistamine use, antipsychotic use with anticholinergic properties, antiparkinsonian anticholinergic use

H. niger alkaloids (scopolamine and hyoscyamine) are muscarinic antagonists. Co-exposure with any medication carrying anticholinergic properties creates additive anticholinergic burden, substantially lowering the threshold for delirium, tachycardia, hyperthermia, urinary retention, and life-threatening toxicity. This is the most clinically dangerous pharmacodynamic interaction class for this substance.

narrow-angle glaucoma, angle-closure glaucoma

Mydriasis is reported in 94.8% of H. niger poisoning cases (Alizadeh 2014). In individuals with narrow anterior chamber angles, anticholinergic mydriasis may trigger acute angle-closure glaucoma, a medical emergency requiring immediate ophthalmological intervention.